Clinical Trial Update: Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on finerenone showing efficacy and safety in subjects with type 2 diabetes and diabetic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: Bayer | Conditions: Diabetic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-04-15